Source: International Congress 2018 – New modalities in asthma treatment
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Bègne (Paris, France), A. Justet (Paris, France), L. Tabèze (Paris, France), C. Dupin (Paris, France), C. Neukirch (Paris, France), R. Borie (Paris, France), M. Dombret (Paris, France), B. Crestani (Paris, France), C. Taillé (Paris, France). Evaluation in a severe asthma expert center improves asthma outcomes.. 1918

Member's Comments

No comment yet.

Related content which might interest you: Assessing severe asthma Source: Eur Respir J 2016; 48: 611-613 Year: 2016 Safety of sputum monitoring in a severe asthma population - The Manchester severe asthma team experience Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Defining acute asthma severity – how do worldwide asthma guidelines compare? Source: International Congress 2018 – The bad and the ugly in paediatric asthma: comorbidities and exacerbations Year: 2018 Predicting frequent exacerbations in a severe asthma centre. Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases Year: 2020 Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Dupilumab improves patient-reported outcomes in uncontrolled persistent asthma patients with ongoing allergic rhinitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Assessing the risk of future severe asthma exacerbations using CARAT questionnaire and lung function Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013 Evaluation of GINA‘s asthma control levels and severity asthma levels in clinical management in children after emergency room visit for asthma crisis Source: Annual Congress 2007 - Childhood asthma: treatment and follow-up Year: 2007 Omalizumab decreases medical resource utilisation in patients with severe allergic asthma in an Italian real-life setting Source: International Congress 2017 – Asthma management Year: 2017 What is the optimal management option for occupational asthma? Source: Eur Respir Rev 2012; 21: 97-104 Year: 2012 Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019 Year: 2020 Acute severe asthma: evidence-based management of asthma exacerbations Source: Annual Congress 2008 - PG4 - Paediatric respiratory medicine: wheezing children: asthma and beyond Year: 2008 Management of difficult-to-treat severe asthma Source: Eur Respir Mon 2011; 51: 282-296 Year: 2011 Assessment of a disease management program for patients with asthma or COPD Source: Eur Respir J 2005; 26: Suppl. 49, 19s Year: 2005 Systematic assessment of difficult-to-treat asthma Source: Eur Respir J 2003; 22: 478-483 Year: 2003 Evaluation of asthma knowledge and quality of life in adult patients with asthma Source: Annual Congress 2011 - Asthma: improving diagnosis and management for reaching better control Year: 2011 Impact of focussed education on accuracy of acute asthma severity assessment Source: Annual Congress 2013 –Monitoring symptoms and quality of life Year: 2013 Evolution from mild to severe asthma; the severe asthma clinic perspective Source: International Congress 2019 – Clinical implications of asthma management Year: 2019 Effectiveness of pulmonary rehabilitation programs on persistent asthma. Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018 Short-term effects of pulmonary rehabilitation on asthma control in patients with moderate-severe unstable asthma Source: International Congress 2019 – Hot topics in pulmonary rehabilitation Year: 2019